BCHT.AMEXBirchtech CORP
10-Q: Birchtech Q3 2025: Revenue Up, Net Loss Narrows Amidst Patent Wins
Sentiment:
Quarterly Report
Birchtech Corp. reported increased revenues and a significantly reduced net loss for the nine months ended September 30, 2025, driven by higher licensing fees and lower operating expenses, despite ongoing patent litigation and a going concern warning.
Delay expectedThe Court in the consolidated Iowa patent infringement actions ruled on October 13, 2025, to stay the litigation pending completion of the Inter Partes Review (IPR) process in the U.S. Patent Trial and Appeal Board (PTAB).The EPA intends to finalize action on its proposal to repeal certain amendments to the MATS Rule by December 2025, indicating ongoing regulatory uncertainty and potential delays in compliance clarity.
Capital raiseManagement is exploring additional financing opportunities to mitigate the substantial doubt about the company's ability to continue as a going concern.
Better than expectedNet loss significantly improved to $2.43 million for the nine months ended September 30, 2025, from $9.46 million in the prior year.Operating loss showed substantial improvement, decreasing from $7.08 million in the nine months ended September 30, 2024, to $1.72 million in 2025.Total revenues increased by approximately $2.0 million, driven by a significant rise in high-margin licensing fees.Cash used in operating activities decreased, indicating improved operational efficiency in cash management.
Summary
- Revenues for the nine months ended September 30, 2025, increased to $13.84 million from $11.84 million in the prior year, primarily due to a significant rise in licensing revenue.
- Net loss for the nine months ended September 30, 2025, improved substantially to $2.43 million, compared to a net loss of $9.46 million for the same period in 2024.
- Operating loss for the nine months ended September 30, 2025, decreased to $1.72 million from $7.08 million in the prior year, driven by increased license fee revenue and a decrease in total operating expenses.
- Selling, general and administrative (SG&A) expenses decreased to $6.62 million for the nine months ended September 30, 2025, from $10.86 million in 2024, mainly due to lower salaries, wages, professional fees, and legal fees.
- Research and development (R&D) expenses increased to $1.34 million for the nine months ended September 30, 2025, as the company began incurring costs related to its new water treatment business.
- The company had a working capital deficiency of approximately $5.03 million at September 30, 2025, worsening from $2.71 million at December 31, 2024.
- Cash and cash equivalents decreased to $1.77 million at September 30, 2025, from $3.46 million at December 31, 2024.
- A federal jury awarded the company a $57.1 million patent infringement verdict in March 2024, with post-trial motions denied in June and September 2025, and a final judgment is pending.
- The company launched a new water treatment business in April 2024, focusing on PFAS and PFOS, and opened two state-of-the-art laboratory facilities (Design Centers).
- Management identified substantial doubt about the company's ability to continue as a going concern within one year from the financial statements' issuance date.
Sentiment
Score: 6
Explanation: The sentiment is moderately positive, reflecting significant improvements in net loss and operating loss, substantial growth in high-margin licensing revenue, and a major patent infringement verdict. The launch of a new water treatment business also presents a strong growth opportunity. However, these positives are tempered by a worsening working capital deficiency, declining cash balance, and a 'going concern' warning, alongside identified material weaknesses in internal controls and ongoing legal uncertainties with IPRs.
Positives
- Total revenues increased by approximately $2.0 million for the nine months ended September 30, 2025, compared to the prior year.
- License revenue saw a significant increase to $3.13 million for the nine months ended September 30, 2025, from $0.27 million in 2024.
- Net loss improved substantially, decreasing from $9.46 million in the nine months ended September 30, 2024, to $2.43 million in the same period of 2025.
- Operating loss significantly decreased from $7.08 million in the nine months ended September 30, 2024, to $1.72 million in 2025.
- SG&A expenses decreased by over $4.2 million for the nine months ended September 30, 2025, primarily due to lower legal fees and bonus compensation.
- Cash used in operating activities improved, decreasing from $3.27 million in the nine months ended September 30, 2024, to $1.66 million in 2025.
- A $57.1 million patent infringement jury verdict was awarded in March 2024, with subsequent court rulings denying defendants' post-trial motions, indicating progress towards collection.
- New licensing agreements were secured with utility defendants, including one-time fees and rights to be included in future bidding processes for product supply.
- The company successfully launched a new water treatment business line and commissioned two state-of-the-art laboratory facilities to support this growth area.
- The Board of Directors authorized a share repurchase program of up to $5.0 million, signaling confidence in the company's valuation.
Negatives
- The company has a working capital deficiency of approximately $5.03 million at September 30, 2025, which worsened from $2.71 million at December 31, 2024.
- Cash and cash equivalents decreased by approximately $1.69 million from December 31, 2024, to September 30, 2025.
- Product revenue decreased to $10.64 million for the nine months ended September 30, 2025, from $11.48 million in the prior year, attributed to plant mix, unexpected customer outages, and product mix.
- The accumulated deficit increased to $75.19 million at September 30, 2025, from $72.75 million at December 31, 2024.
- Management identified material weaknesses in internal control over financial reporting, including a lack of sufficient personnel and insufficient written documentation of policies and procedures.
- The company's ability to continue as a going concern raises substantial doubt due to its financial condition.
Risks
- Changes in general economic and business conditions could adversely affect operations.
- Risks related to the industry, including regulatory changes and competitive pressures, pose ongoing challenges.
- The potential loss of major customers could significantly impact revenue.
- Dependence on the availability and retention of key suppliers is a critical operational risk.
- Risks related to advancements in technologies could render current offerings obsolete.
- Lack of diversification in the business, particularly reliance on the coal-fired utility sector, is a concern.
- Risks related to intellectual property, including the ability to protect it and the success of patent litigation, are significant.
- Changes in demand for coal as a fuel source for electricity production could impact the core business.
- The development and growth of new technologies, particularly in the water treatment market, face inherent uncertainties.
- The ability to retain key personnel is crucial for ongoing operations and strategic initiatives.
- There is a potential that dividends may never be declared.
- Varied, and at times, limited trading activity for common stock, along with volatility in stock price, are market risks.
- Material weaknesses in internal control over financial reporting could adversely affect the ability to record, process, summarize, and report financial information.
Future Outlook
Management expects to mitigate the substantial doubt about its ability to continue as a going concern by receiving additional cash inflows from the $57.1 million jury verdict, securing further licensing revenues and product sales from ongoing patent litigation, and generating revenues from its new water treatment business. The company is also exploring additional financing opportunities. The EPA's evolving regulations on MATS and PFAS are expected to shape market demand, with the company positioning its new sorbent technologies to capture a meaningful share in the rapidly growing water treatment sector.
Management Comments
- Management believes its plans, including expected cash inflows from the $57.1 million jury verdict, additional licensing revenues, product sales from patent litigation, and revenues from the water treatment business, will alleviate substantial doubt about the company's ability to continue as a going concern.
- Management is exploring additional financing opportunities to support the company's financial condition.
- The company believes its complete science and engineering approach for mercury-sorbent-flue gas interactions is well-understood, highly predictive, and critical to delivering total mercury control.
- The company views patent litigation as a last resort, with the goal and overall strategy to convert infringers to its supply chain of sorbent products for mercury removal or license its patents on a non-exclusive basis.
- The company believes its new water treatment solutions, designed to use significantly less activated carbon, offer a more environmentally sustainable approach while maintaining or improving contaminant removal performance.
- The Design Centers represent the only known facilities in North America with integrated capability to thermally reactivate spent GAC under controlled conditions and conduct RSSCTs to compare reactivated GAC performance against virgin carbon.
Industry Context
The company operates within the environmental technology sector, specifically addressing mercury emissions from coal-fired power plants and 'forever chemicals' (PFAS/PFOS) in water treatment. The mercury emissions control market is heavily influenced by EPA regulations like MATS, which have seen proposed strengthening and subsequent reconsideration/exemptions under different presidential administrations, creating regulatory uncertainty. The water treatment market, particularly for PFAS, is experiencing significant growth driven by new national, enforceable drinking water standards issued by the EPA. The company's strategic pivot into water treatment with its Design Centers positions it to capitalize on this emerging market, offering sustainable solutions that align with evolving environmental concerns and regulatory mandates, despite potential shifts in enforcement priorities.
Comparison to Industry Standards
- The filing does not provide specific comparable companies, projects, or results to assess the company's performance against global benchmarks or industry standards.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Executive Director of Innovation and Commercialization | N/A | David Mazyck | 2025-06-01 | Appointment to head the new water business line and focus on innovation and commercialization. |
| Director of National Sales | N/A | Dennis Baranik | 2024-05-01 | Appointment to oversee product sales and IP licensing in the core business and support water market development. |
| Director of Strategic Operations | N/A | Christopher Rinaldi | 2025-06-01 | Appointment with a focus on the water treatment business. |
| Director (Board Member) | N/A | New Director (unnamed) | 2024-12-30 | Election to the Board of Directors. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Internal Control Weaknesses | Identified material weaknesses in internal control over financial reporting due to (i) lack of a sufficient complement of personnel commensurate with reporting requirements and (ii) insufficient written documentation or training of internal control policies and procedures. | 2025-09-30 | These weaknesses indicate a risk to the reliability of financial reporting, although management believes the financial statements fairly present the financial position. |
| Equity Incentive Plan Amendments | Board approved non-material amendments to the Amended and Restated 2014 Equity Incentive Plan and 2017 Equity Incentive Plan in connection with the listing on the Toronto Stock Exchange (TSX). | 2024-10-29 | Ensures compliance with TSX listing requirements for equity compensation plans. |
Legal Proceedings
- A federal jury returned a $57.1 million verdict in favor of the company against CERT defendants for willful patent infringement on March 1, 2024. The Court denied defendants' post-trial motions regarding implied license (June 10, 2025) and liability for induced/contributory/willful infringement (September 25, 2025). The company is awaiting the Court's determination as to the final judgment.
- The company commenced three additional patent infringement lawsuits in July 2024 (Arizona, Iowa, Missouri) and an additional suit in January 2025 (Missouri, Kansas) against multiple utilities and related entities.
- The U.S. Judicial Panel on Multidistrict Litigation ordered the consolidation of these lawsuits in the U.S. District Court for the Southern District of Iowa for coordinated pretrial proceedings on December 17, 2024.
- Several licensing agreements were reached with utility defendants between October 2024 and October 2025, providing non-exclusive licenses for the company's two-part Sorbent Enhancement Additive (SEA) process, including one-time fees and rights to bid for product supply. Some of these utilities agreed to withdraw from Inter Partes Review (IPR) petitions.
- Between January and July 2025, certain defendants in the consolidated Iowa actions filed IPR petitions with the U.S. Patent and Trademark Office seeking to invalidate various asserted claims. The U.S. Patent Trial and Appeal Board (PTAB) granted the institution of review of certain asserted patents in September and October 2025.
- On October 13, 2025, the Court in the consolidated Iowa actions ruled to stay the litigation pending completion of the IPR process in the PTAB.
Related Party Transactions
- Kaye Cooper Kay & Rosenberg, LLP, a law firm where David M. Kaye (a Director) is a partner, provided legal services to the company. The company incurred $112,500 and $337,500 for legal services for the three and nine months ended September 30, 2025, respectively. $37,500 was owed to the firm at September 30, 2025.
- The company has a License and Supply Agreement with Dakin Holdings Ltd., a company owned and controlled by the company's Chief Executive Officer and President. Monthly license fees of $12,500 were paid until September 30, 2024, after which they were eliminated by an amendment on November 18, 2024. No license fees were incurred for the three and nine months ended September 30, 2025.
Stakeholder Impact
- Shareholders: Potential for increased value from successful patent litigation and new water treatment business, but also risk of dilution from potential capital raises and stock price volatility. The share repurchase program could provide support.
- Employees: New hires and appointments in the water treatment business indicate growth opportunities, while stock-based compensation aligns incentives.
- Customers: Continued provision of mercury emissions control solutions and introduction of new water treatment technologies offer expanded services. Fixed-price contracts expose the company to material cost risks.
- Creditors: The profit share liability to AC Midwest is non-recourse and dependent on net litigation proceeds, linking repayment to legal outcomes. Debt restructuring has reduced immediate obligations.
- Regulatory Authorities: The company's operations are directly impacted by EPA regulations on mercury emissions and PFAS, requiring continuous adaptation and compliance.
Next Steps
- Awaiting the Court's determination as to the final judgment for the $57.1 million patent infringement verdict against the CERT defendants.
- Litigation in the consolidated Iowa actions is stayed pending completion of the Inter Partes Review (IPR) process in the U.S. Patent Trial and Appeal Board (PTAB).
- EPA intends to finalize action on its proposal to repeal certain amendments to the MATS Rule by December 2025.
- Continue to develop and commercialize water purification technologies, including plans for future commercial thermal reactivation plants based on data from Design Centers.
- Management is exploring additional financing opportunities to address the going concern risk.
Key Dates
| Date | Description |
|---|---|
| 2015-07-01 | Company entered into a five-year lease for warehouse space in Corsicana, Texas. |
| 2016-11-01 | Restated financing agreement entered with AC Midwest Energy, LLC. |
| 2016-11-29 | Company closed on a secured note (AC Midwest Secured Note) and an unsecured note (AC Midwest Subordinated Note) with AC Midwest. |
| 2018-12-15 | Original maturity date of the AC Midwest Secured Note. |
| 2019-02-25 | Amendment No. 3 extended the AC Midwest Secured Note maturity to August 25, 2022. Company entered into an Unsecured Note Financing Agreement with AC Midwest, issuing the AC Midwest Unsecured Note ($13,154,931 principal) which replaced the AC Midwest Subordinated Note. |
| 2019-07-01 | Company initiated patent litigation against various defendants in the U.S. District Court for the District of Delaware. |
| 2020-07-01 | Start of period during which the Company entered into agreements with four major utility defendants, dismissing claims. |
| 2021-01-31 | End of period during which the Company entered into agreements with four major utility defendants, dismissing claims. |
| 2022-08-25 | Original maturity date of the AC Midwest Unsecured Note. |
| 2022-08-30 | AC Midwest agreed to extend the maturity date of the AC Midwest Unsecured Note (and Secured Note) to September 30, 2022. |
| 2022-09-28 | AC Midwest agreed to an additional short-term extension of the maturity date to October 31, 2022. |
| 2022-10-28 | Amendment No. 4 extended the AC Midwest Secured Note maturity to August 25, 2025. Amendment No. 1 to Unsecured Note Financing Agreement extended the AC Midwest Unsecured Note maturity to August 25, 2025, and increased the Profit Share to $17,654,931. |
| 2022-11-08 | Company issued 3,000,000 shares of common stock to the Chief Executive Officer, which became fully vested on November 8, 2024. |
| 2023-01-01 | Effective date of the License and Supply Agreement with Dakin Holdings Ltd. |
| 2023-01-31 | Company entered into a License and Supply Agreement with Dakin Holdings Ltd., effective as of January 1, 2023. |
| 2023-07-03 | Board of Directors approved and adopted the Amended and Restated 2014 Equity Incentive Plan and the Amended and Restated 2017 Equity Incentive Plan. |
| 2023-11-01 | Company entered into a confidential binding term sheet with Arthur J. Gallagher & Co. and DTE Energy Resources LLC to resolve patent litigation. Alistar Enterprises, LLC entered into a settlement agreement. |
| 2023-12-01 | Company entered into a paid license agreement with Chem-Mod LLC, Arthur J. Gallagher & Co., and DTE Energy Co. |
| 2024-01-15 | Company granted nonqualified stock options to acquire 1,000,000 shares and 50,000 restricted share units (RSUs) to a director. |
| 2024-02-27 | Company paid AC Midwest $275,625 (remaining principal $271,686 + interest $3,939) on the AC Midwest Secured Note. Entered into an Unsecured Debt Restructuring Agreement with AC Midwest, paying $9,040,000 against the AC Midwest Unsecured Note and issuing a new unsecured replacement note (New Note) for $4,114,931. |
| 2024-03-01 | A federal jury returned a $57.1 million verdict in favor of the Company against the remaining CERT defendants for patent infringement. |
| 2024-03-11 | Private sale of shares for $960,000 was completed, applied as a credit against the principal balance due on the New Note. |
| 2024-03-28 | The Corsicana warehouse lease was further extended for an additional five years from March 31, 2024, to March 31, 2029. |
| 2024-04-01 | EPA issued the first-ever national, enforceable drinking water standard to protect communities from exposure to harmful PFAS. Company announced the introduction of its new water treatment business. |
| 2024-05-01 | Company announced the appointment of David Mazyck to head its new water treatment business line. Dennis Baranik was appointed Director of National Sales. EPA finalized and published a proposal to strengthen and update MATS, with an effective date of July 8, 2024. |
| 2024-06-24 | Company issued 886,456 shares of common stock to the CEO and 672,867 shares to the SVP and CTO upon cashless exercise of options. |
| 2024-06-28 | Company issued shares of common stock to employees upon cashless exercise of options. |
| 2024-07-01 | Company commenced three additional patent infringement lawsuits in U.S. District Courts in Arizona, Iowa, and Missouri. |
| 2024-07-08 | Effective date of the 2024 updated MATS Rule. |
| 2024-08-01 | Company entered into a 3-year lease for laboratory space in Grand Forks, North Dakota. |
| 2024-08-03 | Company issued 32,112 shares of common stock to a former consultant upon a cashless exercise of an option. |
| 2024-08-26 | Company repaid AC Midwest the remaining principal of $3,154,931 on the New Note together with accrued interest of $119,964. |
| 2024-09-30 | Monthly license fees under the Dakin Agreement were eliminated after this date. |
| 2024-10-09 | Company received conditional approval to list its shares of common stock on the TSX. |
| 2024-10-17 | Midwest Energy Emissions Corp. changed its corporate name to Birchtech Corp. Common stock commenced trading under the ticker symbol BCHT. |
| 2024-10-29 | Board approved certain non-material amendments to the 2014 Plan and 2017 Plan. |
| 2024-11-12 | Company's shares commenced trading on the TSX under the ticker symbol BCHT. |
| 2024-11-18 | Amendment to the Dakin Agreement eliminated all further monthly license fees after September 30, 2024. |
| 2024-11-22 | Company entered into an approximate 3-year lease for laboratory space in State College, Pennsylvania. |
| 2024-12-15 | Pennsylvania laboratory lease commenced. |
| 2024-12-17 | U.S. Judicial Panel on Multidistrict Litigation ordered the consolidation of three lawsuits in the U.S. District Court for the Southern District of Iowa for coordinated pretrial proceedings. |
| 2024-12-30 | A new director was elected to the Board. |
| 2024-12-31 | The Facilitation Credit related to the Profit Share liability expired. |
| 2025-01-02 | Company granted a nonqualified stock option under the 2017 Plan to a nonaffiliated third party to acquire 250,000 shares of common stock. |
| 2025-01-09 | Company granted a nonqualified stock option under the 2017 Plan to a new director to acquire 100,000 shares of common stock. |
| 2025-01-15 | 50,000 restricted share units (RSUs) granted on January 15, 2024, vested, and the Company issued 50,000 shares of common stock to a director. |
| 2025-01-01 | Start of period during which certain defendants in the consolidated Iowa actions filed IPR petitions with the U.S. Patent and Trademark Office. |
| 2025-03-12 | Newly appointed EPA administrator under the Trump Administration announced plans to roll back dozens of environmental regulations including the reconsideration of the MATS regulation. |
| 2025-03-19 | Board of Directors authorized a share repurchase program of up to $5.0 million of its common stock. |
| 2025-04-08 | President Trump signed a Proclamation exempting certain stationary sources from compliance with the 2024 updated MATS Rule for two years (July 8, 2027, to July 8, 2029). |
| 2025-05-14 | EPA under the new Trump Administration announced the agency will keep PFOA and PFOS regulations, extend compliance deadlines, establish a federal exemption framework, and reconsider other PFAS regulations. |
| 2025-06-01 | David Mazyck was appointed Executive Director of Innovation and Commercialization. Christopher Rinaldi was appointed Director of Strategic Operations. |
| 2025-06-10 | Court ruled that the CERT defendants failed to prove they had an implied license and denied their motion to alter or amend the non-final judgment. |
| 2025-06-20 | Company issued 318,978 shares of common stock to the CEO and 318,978 shares to the SVP and CTO upon cashless exercise of options. |
| 2025-06-01 | EPA proposed to repeal certain amendments finalized in 2024 to the MATS Rule and return compliance obligations to prior standards. |
| 2025-07-31 | End of period during which certain defendants in the consolidated Iowa actions filed IPR petitions with the U.S. Patent and Trademark Office. |
| 2025-08-05 | Company entered into separate agreements with two affiliated utilities named as defendants in the Southern District of Iowa action. |
| 2025-09-09 | Company entered into an agreement with a utility and its affiliated entities named as defendants in the Western District of Missouri and District of Kansas actions. |
| 2025-09-25 | Court issued a Memorandum Opinion and Order denying the CERT defendants' post-trial motion regarding liability for induced, contributory, or willful infringement. |
| 2025-09-30 | Company entered into an agreement with another utility not named as a defendant in patent litigations but a party to IPR petitions. |
| 2025-09-01 | Start of period during which the U.S. Patent Trial and Appeal Board (PTAB) granted the institution of review of certain of the Company's asserted patents. |
| 2025-10-13 | Court in the consolidated Iowa actions ruled to stay the litigation pending completion of the IPR process in the PTAB. |
| 2025-10-15 | Company entered into an agreement with another utility named as a defendant in the Southern District of Iowa action. |
| 2025-10-31 | End of period during which the U.S. Patent Trial and Appeal Board (PTAB) granted the institution of review of certain of the Company's asserted patents. |
| 2025-11-13 | Date of filing of the Quarterly Report on Form 10-Q. |
| 2025-12-01 | EPA intends to finalize action on the proposal to repeal certain 2024 MATS Rule amendments by this date. |
Recommendation
holdBirchtech Corp. presents a mixed financial picture. The significant reduction in net and operating losses, coupled with a substantial increase in high-margin licensing revenue and a favorable $57.1 million patent verdict, indicates strong operational improvements and potential for future cash inflows. The strategic pivot into the growing water treatment market for PFAS also offers a promising new revenue stream. However, the company's 'going concern' warning, worsening working capital deficiency, and declining cash balance highlight significant liquidity risks. The ongoing legal proceedings, including the stay of litigation pending IPRs, introduce uncertainty regarding the timing and ultimate realization of the patent verdict. Given the balance of strong positive developments against critical financial and legal uncertainties, a 'hold' recommendation is appropriate for a seasoned investor, allowing for observation of how the company addresses its going concern status and resolves its legal and operational challenges.
Keywords
Birchtech, BCHT, SEC 10-Q, Quarterly Report, Financial Results, Patent Litigation, Mercury Emissions, Water Treatment, PFAS, PFOS, Activated Carbon, Environmental Technology, Corporate Governance, Going Concern, Licensing Revenue, Share Repurchase
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.